|  Help  |  About  |  Contact Us

Publication : The schizophrenia risk gene product miR-137 alters presynaptic plasticity.

First Author  Siegert S Year  2015
Journal  Nat Neurosci Volume  18
Issue  7 Pages  1008-16
PubMed ID  26005852 Mgi Jnum  J:224478
Mgi Id  MGI:5662336 Doi  10.1038/nn.4023
Citation  Siegert S, et al. (2015) The schizophrenia risk gene product miR-137 alters presynaptic plasticity. Nat Neurosci 18(7):1008-16
abstractText  Noncoding variants in the human MIR137 gene locus increase schizophrenia risk with genome-wide significance. However, the functional consequence of these risk alleles is unknown. Here we examined induced human neurons harboring the minor alleles of four disease-associated single nucleotide polymorphisms in MIR137. We observed increased MIR137 levels compared to those in major allele-carrying cells. microRNA-137 gain of function caused downregulation of the presynaptic target genes complexin-1 (Cplx1), Nsf and synaptotagmin-1 (Syt1), leading to impaired vesicle release. In vivo, miR-137 gain of function resulted in changes in synaptic vesicle pool distribution, impaired induction of mossy fiber long-term potentiation and deficits in hippocampus-dependent learning and memory. By sequestering endogenous miR-137, we were able to ameliorate the synaptic phenotypes. Moreover, reinstatement of Syt1 expression partially restored synaptic plasticity, demonstrating the importance of Syt1 as a miR-137 target. Our data provide new insight into the mechanism by which miR-137 dysregulation can impair synaptic plasticity in the hippocampus.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

0 Bio Entities

0 Expression